Skip to main content
Equibles

STATE STREET CORP

Position in AKTS — Aktis Oncology, Inc.

CIK 93751 BOSTON, MA
Back to AKTS Full portfolio

Position in AKTS

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$15,599,642
+$7,938,196 QoQ
Shares Held
484,010
+13.0% QoQ
Ownership
0.870%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 114 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 22% Shared 0% None 78%

Common Shares in AKTS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. AKTS ranks #174 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in AKTS

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,599,642 484,010
2026-03-31 $7,661,446 428,253